Enoxaparin Sodium Injection
NDC Package 63323-607-88
Package Information
Enoxaparin Sodium injection is enoxaparin is used to prevent and treat harmful blood clots. This formulation utilizes a injection delivery system. Marketed by Fresenius Kabi Usa, Llc, this product is identified by NDC 63323-607 and is authorized under FDA application NDA020164.
Identification & Billing
- RxCUI: 854228 - enoxaparin sodium 30 MG in 0.3 ML Prefilled Syringe
- RxCUI: 854228 - 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe
- RxCUI: 854228 - 0.3 ML ENX sodium 100 MG/ML Prefilled Syringe
- RxCUI: 854228 - enoxaparin sodium 30 MG per 0.3 ML Prefilled Syringe
- RxCUI: 854235 - enoxaparin sodium 40 MG in 0.4 ML Prefilled Syringe
Clinical Specifications
- Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
- Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Regulatory & Marketing
Hierarchy Structure
- 63323 - Fresenius Kabi Usa, Llc
- 63323-607 - Enoxaparin Sodium
- 63323-607-88 - 10 CELLO PACK in 1 CARTON / 1 SYRINGE in 1 CELLO PACK (63323-607-01) / .6 mL in 1 SYRINGE
- 63323-607 - Enoxaparin Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63323-607). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63323-607-88 identifies a specific commercial package of 10 cello pack in 1 carton / 1 syringe in 1 cello pack (63323-607-01) / .6 ml in 1 syringe of Enoxaparin Sodium, a human prescription drug labeled by Fresenius Kabi Usa, Llc. This injection is formulated for subcutaneous use and contains enoxaparin sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fresenius Kabi Usa, Llc on June 18, 2019. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Enoxaparin is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a "blood thinner." It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other "blood thinners."
How is this Fresenius Kabi Usa, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63323060788. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.